A new mobility score for predicting mortality after hip fracture.
M J Parker, C R Palmer
https://pubmed.ncbi.nlm.nih.gov/8376443/Actively Recruiting
Led by Uppsala University · Updated on 2024-12-03
340
Participants Needed
1
Research Sites
34 weeks
Total Duration
Researchers are evaluating the impact of two surgical treatmentsinternal fixation versus hip arthroplastyon physical function and pain in elderly patients aged 75 and older who have an undisplaced or minimally displaced femoral neck fracture Garden I or II. This substudy is part of a larger ongoing nationwide randomized controlled trial called HipSTHeR, aiming to recruit 340 patients eligible for either surgical option. The goal is to understand differences in recovery related to these two treatments over time. Participants are randomly assigned to receive either internal fixation, which involves using screws, pins, or similar devices, or hip arthroplasty, which includes cemented total or hemiarthroplasty. The specific type of arthroplasty or osteosynthesis is determined by the surgeon. After surgery, patients included in this substudy are contacted a few weeks later by letter and telephone to provide consent and participate in follow-ups conducted at 4 and 12 months via phone and mail. During follow-ups, participants answer questions about their functional abilities and pain. Researchers evaluate outcomes using the New Mobility Score as the primary measure, assessing indoor and outdoor walking and shopping ability. Additional assessments include the WOMAC scale for hip-specific symptoms, the Katz ADL index for daily living activities, cognitive status using ALFI-MMSE, depression symptoms with the Geriatric Depression Scale GDS-15, and morale using the Philadelphia Geriatric Center Morale Scale PGCMS. Data on fracture and treatment are collected from national registries, and the study will continue until 2027, monitoring outcomes at specified intervals.
CONDITIONS
Functional Outcome After ORIF or Arthroplasty for Femoral Neck Fracture
S
Sebastian Mukka, MD, PhD
E
Erika Olofsson, RN
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Uppsala University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Screening and enrollment visit
Duration - Up to 72 hours after fracture
Participants undergo surgery either with internal fixation or hip arthroplasty as determined by their assigned treatment group.
1 surgical visit (in-person)
Duration - 12 months
Participants are contacted by telephone and mail to assess physical function, pain, cognitive status, and well-being at 4 and 12 months after surgery.
2 follow-up contacts (telephone and mail) at 4 and 12 months
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
M J Parker, C R Palmer
https://pubmed.ncbi.nlm.nih.gov/8376443/Olof Wolf, Pontus Sjöholm, Nils P Hailer...
https://pubmed.ncbi.nlm.nih.gov/31964340/Bjarke Viberg, Søren Kold, Ole Brink...
https://pubmed.ncbi.nlm.nih.gov/33040011/Paul T P W Burgers, Rudolf W Poolman, Theodorus M J Van Bakel...
https://pubmed.ncbi.nlm.nih.gov/25948522/Sebastian Mukka, Pontus Sjöholm, Athir Aziz...
https://pubmed.ncbi.nlm.nih.gov/32670600/Uppsala University
Lead Sponsor